OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
S-1/temozolomide versus S-1/temozolomide plus thalidomide in advanced pancreatic and non-pancreatic neuroendocrine tumours (STEM): A randomised, open-label, multicentre phase 2 trial
Yihebali Chi, Lijie Song, Weili Liu, et al.
EClinicalMedicine (2022) Vol. 54, pp. 101667-101667
Open Access | Times Cited: 5
Yihebali Chi, Lijie Song, Weili Liu, et al.
EClinicalMedicine (2022) Vol. 54, pp. 101667-101667
Open Access | Times Cited: 5
Showing 5 citing articles:
The effect of enantiomers of thalidomide on colon cells-Raman spectroscopy studies
Monika Kopeć, Agnieszka Krzemińska, Jakub Surmacki, et al.
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy (2025), pp. 126423-126423
Closed Access
Monika Kopeć, Agnieszka Krzemińska, Jakub Surmacki, et al.
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy (2025), pp. 126423-126423
Closed Access
Efficacy and safety of temozolomide-based regimens in advanced pancreatic neuroendocrine tumors: a systematic review and meta-analysis
Erfan Taherifard, Muhammad Bakhtiar, Mahnoor Mahnoor, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Erfan Taherifard, Muhammad Bakhtiar, Mahnoor Mahnoor, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Treatment, Prognostic Markers, and Survival in Thymic Neuroendocrine Tumors, with Special Reference to Temozolomide-Based Chemotherapy
Zixuan Cheng, Fuhuan Yu, Ruao Chen, et al.
Cancers (2024) Vol. 16, Iss. 14, pp. 2502-2502
Open Access
Zixuan Cheng, Fuhuan Yu, Ruao Chen, et al.
Cancers (2024) Vol. 16, Iss. 14, pp. 2502-2502
Open Access
Unraveling the mysteries of MGMT: Implications for neuroendocrine tumors
JianyunJiang, Junfeng Xu, Shunrong Ji, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024), pp. 189184-189184
Closed Access
JianyunJiang, Junfeng Xu, Shunrong Ji, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024), pp. 189184-189184
Closed Access
A Systematic Review and Meta-Analysis to Assess the Efficacy of Different Combinations of Temozolomide and Other Drugs in Patients with Advanced Pancreatic Neuroendocrine Tumors
Muhammad Bakhtiar, Mahnoor Mahnoor, Rabeea Ahmed, et al.
(2023)
Closed Access
Muhammad Bakhtiar, Mahnoor Mahnoor, Rabeea Ahmed, et al.
(2023)
Closed Access
Chinese expert consensus on multidisciplinary diagnosis and treatment of pancreatic neuroendocrine liver metastases
Yihebali Chi, Liming Jiang, Susheng Shi, et al.
Journal of Pancreatology (2023) Vol. 6, Iss. 4, pp. 139-150
Open Access
Yihebali Chi, Liming Jiang, Susheng Shi, et al.
Journal of Pancreatology (2023) Vol. 6, Iss. 4, pp. 139-150
Open Access
